OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy-Reference-Cited by-同舟云学术

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy

Published:2015-02-15 Issue:1 Volume:14 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Shibahara Ichiyo,Saito Ryuta,Zhang Rong,Chonan Masashi,Shoji Takuhiro,Kanamori Masayuki,Sonoda Yukihiko,Kumabe Toshihiro,Kanehira Masahiko,Kikuchi Toshiaki,So Takanori,Watanabe Takashi,Takahashi Hiroaki,Iwabuchi Erina,Tanaka Yuetsu,Shibahara Yukiko,Sasano Hironobu,Ishii Naoto,Tominaga Teiji

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-015-0307-3.pdf

Reference34 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

2. Johnson LA, Sampson JH. Immunotherapy approaches for malignant glioma from 2007 to 2009. Curr Neurol Neurosci Rep. 2010;10:259–66.

3. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity. 2001;15:445–55.

4. Sugamura K, Ishii N, Weinberg AD. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol. 2004;4:420–31.

5. Ishii N, Takahashi T, Soroosh P, Sugamura K. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63–98.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation immunodynamics in patients with glioblastoma receiving chemoradiation;Frontiers in Immunology;2024-09-13

2. The necessary role of an efficient tumor immunotherapy by MHC II expression on amateur APCs;Malignancy Spectrum;2024-05-31

3. From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review;Journal of Experimental & Clinical Cancer Research;2024-02-12

4. Shorter survival time of adolescents and young adult patients than older adults with spinal cord glioblastoma: a multicenter study;Journal of Neurosurgery: Spine;2023-11-01

5. OX40-Ligand Enhances H7N9 Whole Inactivated Virus Vaccine-induced Antibody Responses by Promoting Proliferation of Follicular Helper T Cells and Germinal Centre B Cells;2023-10-17